News
Retatrutide vs. Semaglutide for Visceral Fat Lo...
Phase 2 data on retatrutide, a triple-hormone agonist, suggest greater weight loss than semaglutide, but its impact on visceral fat and body recomposition
Retatrutide vs. Semaglutide for Visceral Fat Lo...
Phase 2 data on retatrutide, a triple-hormone agonist, suggest greater weight loss than semaglutide, but its impact on visceral fat and body recomposition